Cargando…
Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
INTRODUCTION: Breast cancer affects two million patients worldwide every year and is the most common cause of cancer-related death among women. The triple-negative breast cancer (TNBC) sub-type is associated with an especially poor prognosis because currently available therapies fail to induce long-...
Autores principales: | Manouchehri, Jasmine M., Datta, Jharna, Willingham, Natalie, Wesolowski, Robert, Stover, Daniel, Ganju, Ramesh K., Carson, William E., Ramaswamy, Bhuvaneswari, Cherian, Mathew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065442/ https://www.ncbi.nlm.nih.gov/pubmed/35515134 http://dx.doi.org/10.3389/fonc.2022.855032 |
Ejemplares similares
-
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
por: Mal, Rahul, et al.
Publicado: (2020) -
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022) -
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020) -
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Johnson, Kai Conrad Cecil, et al.
Publicado: (2023) -
The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
por: Bhateja, Priyanka, et al.
Publicado: (2019)